Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
FCGR2B Biologics Sequence Review Report 2026: Low affinity immunoglobulin gamma Fc region receptor II-b Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of FCGR2B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD247 Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD3 zeta chain Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD247 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR50 Biologics Sequence Review Report 2026: Melatonin-related receptor Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR50 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
KLRD1 Biologics Sequence Review Report 2026: Natural killer cells antigen CD94 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of KLRD1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
KLRB1 Biologics Sequence Review Report 2026: Killer cell lectin-like receptor subfamily B member 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of KLRB1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PTPRJ Biologics Sequence Review Report 2026: Receptor-type tyrosine-protein phosphatase eta Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of PTPRJ protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
KLRC3 Biologics Sequence Review Report 2026: NKG2-E type II integral membrane protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of KLRC3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR143 Biologics Sequence Review Report 2026: G protein-coupled receptor 143 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR143 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR15 Biologics Sequence Review Report 2026: G protein-coupled receptor 15 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR15 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR12 Biologics Sequence Review Report 2026: G protein-coupled receptor 12 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR12 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR6 Biologics Sequence Review Report 2026: G protein-coupled receptor 6 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR6 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
GPR4 Biologics Sequence Review Report 2026: G protein-coupled receptor 4 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GPR4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
188
189
190
191
192
>>
1503
>